Amplification of CCNE1 is associated with many cancer progressions including gastric cancer, bladder cancer, ovarian cancer and triple negative breast cancer and linked to poor prognosis.40, 41, 42, 43. This evidence concerns the gene CCNE1 and urinary bladder carcinoma.